You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Carcinoma, Medullary

Showing 1 - 25 of 7,841
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Medullary Thyroid Cancer, Medullary Thyroid Carcinoma, Thyroid Carcinoma, Medullary Trial in Groningen (18F-PSMA-1007)

Not yet recruiting
  • Medullary Thyroid Cancer
  • +3 more
  • Groningen, Netherlands
    University Medical Centre Groningen
Sep 8, 2022

Kidney Medullary Carcinoma, Loss of INI 1 Protein Expression, Stage III Renal Cell Cancer AJCC v8 Trial in Houston (Ipilimumab,

Active, not recruiting
  • Kidney Medullary Carcinoma
  • +3 more
  • Ipilimumab
  • Nivolumab
  • Houston, Texas
    M D Anderson Cancer Center
Sep 22, 2022

Medullary Colonic Carcinoma

Completed
  • Medullary Carcinoma of Colon
  • +2 more
    • Limoges, France
      Service de Chirurgie Digestive et Endocrinienne du CHU de Limoge
    Jan 7, 2022

    Medullary Thyroid Carcinoma, Nodular Goiter Trial in Pilar (Fine Needle Aspiration Cytology (FNAC) procedure+calcitonin

    Completed
    • Medullary Thyroid Carcinoma
    • Nodular Goiter
    • Fine Needle Aspiration Cytology (FNAC) procedure+calcitonin measurement
    • Pilar, Buenos Aires, Argentina
      Hospital Universitario Austral
    Oct 5, 2023

    Surgical Management of Advanced Thyroid Cancer

    Recruiting
    • Thyroid Carcinoma
    • +6 more
    • Thyroidectomy with or without lymphadenectomy or multivisceral resection
    • Rome, Italy
      Fondazione Policlinico Universitario Agostino Gemelli IRCCS
    Mar 31, 2023

    Carcinomas, Renal Medullary Carcinoma Trial in Houston (Nivolumab, Relatlimab)

    Not yet recruiting
    • Carcinomas
    • Renal Medullary Carcinoma
    • Houston, Texas
      MD Anderson Cancer Center
    Apr 20, 2022

    DOTATOC PET/CT for Imaging NET Patients

    Recruiting
    • Neuroendocrine Tumors
    • +15 more
    • 68Ga-DOTATOC PET/CT
    • 18F-FDG PET/CT
    • Vancouver, British Columbia, Canada
      BC Cancer
    Nov 2, 2022

    Malignant Thyroid Gland Tumor, Poorly Differentiated Thyroid Gland Carcinoma, Recurrent Thyroid Gland Carcinoma Trial in Houston

    Recruiting
    • Malignant Thyroid Gland Neoplasm
    • +6 more
    • Quality-of-Life Assessment
    • +3 more
    • Ann Arbor, Michigan
    • +1 more
    Jan 24, 2023

    Bronchial and Thymic Neuroendocrine Tumour, Paraganglioma/ Phaeochromocytoma, Medullary Thyroid Carcinoma Trial (Lu-177 DOTATATE

    Not yet recruiting
    • Bronchial and Thymic Neuroendocrine Tumour
    • +3 more
    • Lu-177 DOTATATE (Lutathera®)
    • (no location specified)
    Nov 1, 2023

    Non-Medullary Thyroid Carcinoma Trial (Digoxin tablet)

    Not yet recruiting
    • Non-Medullary Thyroid Carcinoma
    • Digoxin tablet
    • (no location specified)
    Aug 20, 2022

    A Detailed Look At What Patients Experience In Medullary Thyroid

    Not yet recruiting
    • Medullary Thyroid Cancer
      • San Francisco, California
        Power Life Sciences
      Oct 6, 2023

      Diabetes, Diabetes, Type 2, Medullary Thyroid Carcinoma Trial in Morgantown (No treatment given)

      Enrolling by invitation
      • Diabetes
      • +3 more
      • No treatment given
      • Morgantown, West Virginia
        United BioSource, LLC
      Oct 4, 2022

      Epithelioid Sarcoma (Ex-US Only), Spindle Cell Sarcoma, Sinonasal Carcinoma Trial (Tazemetostat)

      Temporarily not available
      • Epithelioid Sarcoma (Ex-US Only)
      • +19 more
      • (no location specified)
      Oct 17, 2022

      Metastatic Kidney Medullary Carcinoma, Metastatic Renal Cell Carcinoma, SMARCB1 Negative Trial in Houston (Doxorubicin,

      Recruiting
      • Metastatic Kidney Medullary Carcinoma
      • +4 more
      • Houston, Texas
        M D Anderson Cancer Center
      Jan 20, 2023

      Breast Cancer, Colon Cancer, Extrahepatic Bile Duct Cancer Trial in Duarte (procedure, other, drug)

      Active, not recruiting
      • Breast Cancer
      • +11 more
      • radionuclide imaging
      • +4 more
      • Duarte, California
        City of Hope Medical Center
      Oct 20, 2022

      Medullary Thyroid Carcinoma Trial in Angers, Nantes, Saint-Herblain (• TF2 and 68 Ga-IMP-288)

      Completed
      • Medullary Thyroid Carcinoma
      • • TF2 and 68 Ga-IMP-288
      • Angers, France
      • +2 more
      Jul 22, 2022

      Medullary Thyroid Cancer Trial in Cordoba, Sevilla (Pralsetinib, Cabozantinib, Vandetanib)

      Not yet recruiting
      • Medullary Thyroid Cancer
      • Cordoba, Spain
      • +1 more
      Jan 11, 2023

      RET-altered Non Small Cell Lung Cancer, Medullary Thyroid Cancer, RET-altered Papillary Thyroid Cancer Trial in Chang chun

      Not yet recruiting
      • RET-altered Non Small Cell Lung Cancer
      • +3 more
      • Chang chun, Jilin, China
        Jinlin Province Cancer Hosipital
      Dec 21, 2022

      Medullary Thyroid Cancer Trial in China (Anlotinib Hydrochloride Capsule)

      Recruiting
      • Medullary Thyroid Cancer
      • Anlotinib Hydrochloride Capsule
      • Hefei, Anhui, China
      • +18 more
      Apr 14, 2023

      Metastatic Medullary Thyroid Cancer Trial in Philadelphia (single dose of CART-GFRa4 cells, Fludarabine, Cyclophosphamide)

      Recruiting
      • Metastatic Medullary Thyroid Cancer
      • single dose of CART-GFRa4 cells
      • +2 more
      • Philadelphia, Pennsylvania
        University of Pennsylvania
      Sep 16, 2022

      Adrenal Cortical Carcinoma, Medullary Thyroid Cancer, Thymic Neuroendocrine Carcinoma Trial in Shanghai (individualized mRNA

      Not yet recruiting
      • Adrenal Cortical Carcinoma
      • +3 more
      • individualized mRNA neoantigen vaccine (mRNA-0523-L001)
      • Shanghai, Shanghai, China
        Ruijin hospital, Shanghai Jiao-Tong University School of Medicin
      Nov 19, 2023

      Children and Adults With Medullary Thyroid Cancer

      Recruiting
      • Medullary Thyroid Cancer
        • Bethesda, Maryland
          National Institutes of Health Clinical Center, 9000 Rockville Pi
        Apr 7, 2022

        Cardiovascular Disorder, Chronic Kidney Disease, Metastatic Renal Cell Carcinoma Trial in United States (Best Practice, Blood

        Recruiting
        • Cardiovascular Disorder
        • +8 more
        • Best Practice
        • +4 more
        • Creve Coeur, Missouri
        • +24 more
        Aug 10, 2022

        Trained Immunity in Thyroid Carcinoma and Colon Carcinoma

        Recruiting
        • Thyroid Cancer, Nonmedullary
        • Colon Carcinoma
        • no intervention will take place
        • Nijmegen, Gelderland, Netherlands
          RadboudUMC
        Sep 21, 2022

        Differentiated Thyroid Gland Carcinoma, Malignant Adrenal Gland Pheochromocytoma, Malignant Paraganglioma Trial in Houston

        Active, not recruiting
        • Differentiated Thyroid Gland Carcinoma
        • +3 more
        • Computed Tomography
        • +6 more
        • Houston, Texas
          M D Anderson Cancer Center
        Feb 17, 2022